TY - JOUR
T1 - Re-evaluating herd protection by VI typhoid vaccine in a cluster randomized trial
AU - Ali, Mohammad
AU - Sur, Dipika
AU - Kanungo, Suman
AU - Qadri, Firdausi
AU - Kim, Deok Ryun
AU - Islam, Taufiqul
AU - Im, Justin
AU - Ahmmed, Faisal
AU - Chon, Yun
AU - Khan, Ashraful Islam
AU - Zaman, K.
AU - Marks, Florian
AU - Dutta, Shanta
AU - Bhattacharya, Sujit K.
AU - Clemens, John D.
N1 - Funding Information:
Funding: This study was supported by a grant (OPP1171432) from the Bill & Melinda Gates Foundation. The study was also supported by core grants to the International Centre for Diarrhoeal Disease Research, Bangladesh.
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
PY - 2019/6/28
Y1 - 2019/6/28
N2 - Background: In a cluster randomized trial (CRT) of a Vi polysaccharide vaccine against typhoid in the slums of Kolkata we found evidence of vaccine herd protection. However, transmission of typhoid into clusters from the outside likely occurred in this densely populated setting, which could have diminished our estimates of vaccine herd protection. Methods: Eighty clusters (40 in each arm) were randomised to receive a single dose of either Vi or inactivated hepatitis A vaccine. We analysed protection for the entire cluster and for subclusters consisting of residents of the innermost households. Results: During 2 y of follow-up, total protection was 61% (95% CI 41 to 75), overall protection was 57% (95% CI 37 to 71) and indirect protection was 44% (95% CI 2 to 69). Analyses of the innermost 75% and 50% of households of the clusters showed similar findings. However, in the innermost 25% of households of the clusters, total protection was 82% (95% CI 48 to 94) and overall protection was 66% (95% CI 27 to 84). There was not a sufficient sample size to demonstrate such a trend for indirect protection in these innermost households. Conclusions: The findings suggest that analyses of the entire cluster may have led to underestimation of herd protection against typhoid by Vi vaccine and that restriction of the analyses to the inner subclusters may have led to a more accurate estimation of vaccine herd effects.
AB - Background: In a cluster randomized trial (CRT) of a Vi polysaccharide vaccine against typhoid in the slums of Kolkata we found evidence of vaccine herd protection. However, transmission of typhoid into clusters from the outside likely occurred in this densely populated setting, which could have diminished our estimates of vaccine herd protection. Methods: Eighty clusters (40 in each arm) were randomised to receive a single dose of either Vi or inactivated hepatitis A vaccine. We analysed protection for the entire cluster and for subclusters consisting of residents of the innermost households. Results: During 2 y of follow-up, total protection was 61% (95% CI 41 to 75), overall protection was 57% (95% CI 37 to 71) and indirect protection was 44% (95% CI 2 to 69). Analyses of the innermost 75% and 50% of households of the clusters showed similar findings. However, in the innermost 25% of households of the clusters, total protection was 82% (95% CI 48 to 94) and overall protection was 66% (95% CI 27 to 84). There was not a sufficient sample size to demonstrate such a trend for indirect protection in these innermost households. Conclusions: The findings suggest that analyses of the entire cluster may have led to underestimation of herd protection against typhoid by Vi vaccine and that restriction of the analyses to the inner subclusters may have led to a more accurate estimation of vaccine herd effects.
KW - Clinical trial registration: ClinicalTrials.gov
KW - NCT00125008
KW - VI polysaccharide vaccine
KW - cluster randomized trial
KW - fried egg design
KW - typhoid fever
KW - vaccine effectiveness
UR - http://www.scopus.com/inward/record.url?scp=85077951450&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85077951450&partnerID=8YFLogxK
U2 - 10.1093/inthealth/ihz069
DO - 10.1093/inthealth/ihz069
M3 - Article
C2 - 31608962
AN - SCOPUS:85077951450
SN - 1876-3413
VL - 12
SP - 36
EP - 42
JO - International health
JF - International health
IS - 1
ER -